Buy & Sell iShares 0 3 Month Treasury Bond ETF (SGOV) – iShares 0 3 Month Treasury Bond ETF Price Today
Aura AI Summary
Key Stats
- -Market Cap
- Fixed IncomeSector
- -0.27%3M Drawdown
- -Enterprise Value
- -Dividend Yield
- 63% Buy | 37% SellTrading Activity
- 22 daysTypical Hold Time
Over the past 52 weeks, iShares 0 3 Month Treasury Bond ETF has traded between a low of $100.28 and a high of $100.74, highlighting its annual price range. Over the past three months, iShares 0 3 Month Treasury Bond ETF has recorded a drawdown of -0.27%, reflecting recent price volatility. On average, investors hold iShares 0 3 Month Treasury Bond ETF for approximately 22 days, indicating typical investor behavior on the platform.
About iShares 0 3 Month Treasury Bond ETF
SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Most Recent News
Investigation into Wealthfront's securities fraud continues amid sharp stock drops and deposit declines.
Glancy Prongay & Murray LLP is investigating Wealthfront Corporation for potential securities law violations after the company reported significant financial setbacks. Wealthfront's stock fell sharply following disclosures of large net deposit outflo...

ControlUp named Leader for third year in Gartner's 2026 Digital Employee Experience Magic Quadrant.
ControlUp has been recognized as a Leader for the third consecutive year in Gartner's 2026 Magic Quadrant for Digital Employee Experience (DEX) Management Tools. This highlights ControlUp's innovation in Autonomous Endpoint Management using agentic A...

Gilead and Merck halt lung cancer trial but report positive HIV drug Phase 3 results.
Gilead Sciences and Merck have stopped their Phase 3 trial combining Trodelvy and Keytruda for metastatic non-small cell lung cancer after it failed to show statistically significant benefits. However, they announced positive Phase 3 results for a ne...
